APP13007 is a novel aqueous nanosuspension formulation for the treatment of inflammation and pain following ocular surgery
Nous-209 has been developed using the Nouscom's viral vector platform
Organ Transplants triple across the country; rise from 5000 (2013) to more than 15000 in 2022
The consolidated EBITDA stood at Rs. 89.3 crore in FY23 as compared to Rs. 164.5 crore in the same period last year
The committee voted that FDA should restrict use of LYNPARZA plus abi/pred to these BRCAm mCRPC patients
Specialty Chemicals grew 38% YoY for FY23
The news on a shift in its focus comes after the refinement of Bayer’s early innovation framework
Malaria is a life-threatening parasitic infection that is spread by the bites of mosquitoes carrying the Plasmodium parasite
This is the first time the Agency has authorized the Phase 3 clinical evaluation in the U.S of a microbiota-based live biotherapeutic based on a pooling technology
Subscribe To Our Newsletter & Stay Updated
